THE CLOTTING PROBLEM
WHAT IS A BLOOD CLOT?
A blood clot that forms in the leg is called deep vein thrombosis (DVT). If the blood clot breaks loose and travels up to your lungs, it is called a pulmonary embolism (PE). Together, they are known as venous thromboembolism.
It’s Preventable
Reports suggest that as many as 70% of cases of HA-VTE in patients could be prevented²¹
It’s Frequent
In the hospital setting, roughly 1 out of 10 deaths are related to blood clots²¹
Blood clots are the leading cause of preventable hospital death²³
Healthcare-associated venous thromboembolism (HA-VTE) is a significant, deadly, costly, and growing public health problem.
It has been estimated that up to 900,000 blood clots occur per year, resulting in approximately 100,000-300,000 deaths. The total number of people who lose their lives each year to clotting-related complications is higher than AIDs, breast cancer, and motor vehicle crashes combined.²²
Preventable DVT alone costs an estimated $2.5B annually, with each case resulting in a direct hospital cost of $25,977.²²
In the hospital, blood clot prevention is attacked from two angles - thinning the blood through pharmacological agents and replicating ambulation to mechanically move blood through the circulatory system.
The medical community collectively agrees that highly acute patients need both means of prevention, yet specific patient populations like oncology, surgical, and trauma can have limitations with pharmacologic therapy due to bleeding risk and drug-to-drug interactions.
The MAC System is designed to mimic our body’s natural physiological return of blood back to the heart through the pump of the calf muscle. The system’s proprietary force algorithms deliver three times over baseline femoral vein response to avoid venous stasis during recovery.
